Status:
COMPLETED
A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in Depression
Lead Sponsor:
NYU Langone Health
Conditions:
Depression
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Depression and other psychiatric conditions are marked by exaggerated, preferential processing (or attention bias) of negative information relative to neutral or positive information. This depression-...
Detailed Description
This prospective pilot study will recruit 25 female participants, ages 18-45 (inclusive), with mild to moderate depression (based on BDI-II score range 14-19 for mild and 20-28 for moderate) to determ...
Eligibility Criteria
Inclusion
- Aged 18-45
- Female
- Mild to moderate depression (determined by BDI-II scores of 14-19 and 20-28, respectively)
- If taking antidepressants, medication must be stable ≥ 30 days prior to screening
Exclusion
- Wide-Range Achievement Test-Fourth Edition (WRAT-4) Reading Subtest standard score \<85 (to ensure understanding of test procedures)
- Insufficient visual and motor ability to operate the intervention and assessments as judged by treating neurologist or study staff
- Primary psychiatric disorder other than depression (based on MINI)
- Primary neurologic condition that would prevent ability to participate (as determined by study clinician).
- History of head trauma in the last year
- Medical device implants in the head or neck
- History or current uncontrolled seizure disorder
- Current substance abuse disorder
- . Pregnant or lactating women
- Skin disorder/sensitive skin near stimulation locations
Key Trial Info
Start Date :
December 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05188248
Start Date
December 15 2021
End Date
December 14 2022
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 100176